| Serial Number | 79392436 |
| Word Mark | LIVESPO A FUTURE WITHOUT ANTIBIOTICS |
| Filing Date | Thursday, November 30, 2023 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Wednesday, February 12, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the stylized wording LIVESPO with the wording LIVE being in grey and SPO being in dark blue. Below this wording appears the smaller stylized wording A FUTURE WITHOUT ANTIBIOTICS in grey. All the aforementioned appears on a white background. |
| Description of the Colors Claimed | The color grey appears on the wording "Live" and "A Future Without Antibiotics", the color dark blue appears on the wording "Spo" and the color white is in the background of the mark. |
| Goods and Services | Pharmaceuticals, namely, pharmaceutical preparations for supportive treatment and prevention of the following conditions: (1) intestinal diseases, including dysbiosis (imbalanced microbiota), inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), diarrhea, constipation, anorexia, and underweight; (2) respiratory diseases, such as runny nose, nasal congestion, allergic rhinitis, cough, and respiratory infections caused by RSV and influenza virus; (3) dental diseases, including tooth decay and periodontitis; (4) vaginal conditions, such as itching, irritation, unpleasant odor, abnormal discharge, and discoloration of vaginal secretions; and (5) skin diseases, including mild to moderate acne, oily skin, and atopic dermatitis; Dietetic foods adapted for medical use; Bio-products for medical purposes, namely biological preparations for the treatment of supportive treatment and prevention of the following conditions: (1) intestinal diseases, including dysbiosis (imbalanced microbiota), inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), diarrhea, constipation, anorexia, and underweight; (2) respiratory diseases, such as runny nose, nasal congestion, allergic rhinitis, cough, and respiratory infections caused by RSV and influenza virus; (3) dental diseases, including tooth decay and periodontitis; (4) vaginal conditions, such as itching, irritation, unpleasant odor, abnormal discharge, and discoloration of vaginal secretions; and (5) skin diseases, including mild to moderate acne, oily skin, and atopic dermatitis. |
| Indication of Colors claimed | The color(s) grey, dark blue and white is/are claimed as a feature of the mark. |
| NOT AVAILABLE | A FUTURE WITHOUT ANTIBIOTICS |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 1, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | LIVESPO GLOBAL JOINT STOCK COMPANY |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | VN |
| Event Date | Event Description |
| Thursday, March 28, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Saturday, June 29, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, July 29, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, April 1, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 5, 2024 | APPLICATION FILING RECEIPT MAILED |
| Thursday, June 27, 2024 | ASSIGNED TO EXAMINER |
| Friday, June 28, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, July 29, 2024 | REFUSAL PROCESSED BY MPU |
| Thursday, January 23, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 23, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, August 17, 2024 | REFUSAL PROCESSED BY IB |
| Thursday, January 23, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 12, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, February 12, 2025 | FINAL REFUSAL WRITTEN |
| Wednesday, February 12, 2025 | FINAL REFUSAL E-MAILED |